SELLAS Life Sciences Group (SLS) Operating Leases: 2019-2024
Historic Operating Leases for SELLAS Life Sciences Group (SLS) over the last 6 years, with Sep 2024 value amounting to $576,000.
- SELLAS Life Sciences Group's Operating Leases fell 10.56% to $576,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $576,000, marking a year-over-year decrease of 10.56%. This contributed to the annual value of $460,000 for FY2023, which is 19.72% down from last year.
- Latest data reveals that SELLAS Life Sciences Group reported Operating Leases of $576,000 as of Q3 2024, which was down 16.76% from $692,000 recorded in Q2 2024.
- SELLAS Life Sciences Group's Operating Leases' 5-year high stood at $1.2 million during Q1 2022, with a 5-year trough of $123,000 in Q1 2020.
- Over the past 3 years, SELLAS Life Sciences Group's median Operating Leases value was $749,000 (recorded in 2023), while the average stood at $792,000.
- Per our database at Business Quant, SELLAS Life Sciences Group's Operating Leases tumbled by 73.89% in 2020 and then soared by 671.54% in 2021.
- Over the past 5 years, SELLAS Life Sciences Group's Operating Leases (Quarterly) stood at $825,000 in 2020, then dropped by 26.06% to $610,000 in 2021, then dropped by 6.07% to $573,000 in 2022, then declined by 19.72% to $460,000 in 2023, then dropped by 10.56% to $576,000 in 2024.
- Its Operating Leases was $576,000 in Q3 2024, compared to $692,000 in Q2 2024 and $801,000 in Q1 2024.